First City Capital Management’s Novo Nordisk NVO Stock Holding History

First City Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,610	Closed	-$230K	–	166
2024 Q2	$230K	Hold	1,610	–	–	0.13%	149
2024 Q1	$207K	Buy	+1,610	New	+$192K	0.11%	166
2016 Q2	–	Sell	-768	Closed	-$20.8K	–	390
2016 Q1	$20.8K	Hold	768	–	–	0.01%	382
2015 Q4	$22.3K	Hold	768	–	–	0.02%	374
2015 Q3	$20.8K	Buy	768 +208	+37%	+$5.89K	0.02%	379
2015 Q2	$15.3K	Buy	560 +400	+250%	+$11.2K	0.01%	397
2015 Q1	$4.27K	Hold	160	–	–	﹤0.01%	487
2014 Q4	$3.39K	Hold	160	–	–	﹤0.01%	520
2014 Q3	$3.81K	Hold	160	–	–	﹤0.01%	502
2014 Q2	$3.69K	Hold	160	–	–	﹤0.01%	517
2014 Q1	$3.65K	Buy	+160	New	+$3.41K	﹤0.01%	509

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First City Capital Management's NVO Position: Q3 2024 in Review

First City Capital Management sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 1,610 shares — an estimated $230K sold.

First City Capital Management first reported a position in NVO in Q1 2014 and held it in 11 quarters. The position peaked at $230K in Q2 2024. 1,787 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

First City Capital Management reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
First City Capital Management sold 1,610 Novo Nordisk shares in Q3 2024, an estimated $230K.
First City Capital Management first reported a position in Novo Nordisk in Q1 2014 and held it in 11 quarters.
First City Capital Management's Novo Nordisk position peaked at $230K in Q2 2024.
1,787 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on First City Capital Management's 13F filing for Q3 2024, filed 7 Nov 2024.